Health Ministry Warns of Dangerous Diet Product After Young Man Hospitalized

Israel's Ministry of Health issued a public warning on Tuesday against a weight-loss product called G-Slim, which is not approved for marketing in the country. The warning follows an enforcement operation where the ministry discovered the product contains a pharmaceutical ingredient banned in Israel and many other nations, which has led to severe health reactions.

A laboratory analysis of G-Slim revealed it contains 53.8 milligrams of Sibutramine per capsule, more than triple the dosage found in a similar product previously outlawed. The ministry noted that no registered products in Israel currently contain Sibutramine.

Sibutramine was banned due to health risks, including potential increases in blood pressure, rapid heartbeat, anxiety, nervousness, insomnia, and in severe cases, heart attacks, strokes, and psychiatric disorders. The risk is considered particularly significant given the unusually high quantity found in G-Slim.

The warning gained urgency after a young man was recently hospitalized with chest pains and a rapid pulse, reportedly after consuming the product. The Ministry of Health urges the public not to use G-Slim and generally advises against purchasing health products from unregulated sources.

Authorities recommend buying medications, supplements, and health products only from approved locations like pharmacies and chain stores, and to avoid purchases through social media, messaging groups, or unfamiliar websites. Individuals who encounter G-Slim or suspect the marketing of counterfeit drugs can report it to the Health Ministry's hotline at *5400. For those seeking to lose weight, the ministry advises consulting a licensed nutritionist and maintaining a healthy diet and exercise routine.